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Abstract
Background: Type 1 diabetes mellitus (T1DM) is an autoimmune 
disease with beta-cell destruction, resulting in insulin deficiency. 
It is now clear that environmental factors also play a role in dis-
ease development. The prevalence of type 1 diabetes in children 
and young people in Portugal is 0.16% between 0 and 19 years of 
age. The main cause of death in T1DM is cardiovascular disease, 
and early endothelial dysfunction is its pathophysiologycal precur-
sor. Hyperglycemia is associated with increased production of free 
radicals and increased oxidative stress. The aim of this study was 
to analyze the antioxidant status in a pediatric portuguese diabetic 
population.
Methods: The study was conducted to characterize and compare 
the antioxidant status in children aged 2 - 10 years old, with type 
1 diabetes and healthy children. Plasmatic profile of total phenolic 
content (TPC), ferric reducing antioxidant power (FRAP), Trolox 
equivalent antioxidant capacity (TEAC) in children with diabetes 
and controls, pre-pubescent, and with BMI < 85th centile were 
evaluated.
Results: FRAP values were significantly lower in diabetic children 
compared with healthy controls (P < 0.001). There was not any statis-
tical significant difference in the TPC and the TEAC determinations.
Conclusions: Young Portuguese diabetic children have a lower anti-
oxidant status than healthy children.
Keywords: Antioxidant; Type 1 diabetes
Introduction
Type 1 diabetes mellitus (T1DM) is an autoimmune disease 
with beta-cell destruction, resulting in insulin deficiency. The 
incidence of pediatric diabetes is increasing for T1DM [1]. A 
genetic predisposition seems to be necessary for developing 
the disease and is most often linked to genes in the HLA-com-
plex [2]. Islet autoantibodies are detected in the majority of 
individuals at the time of diagnosis of T1DM, and these are 
directed against pancreatic proteins like insulin, glutamic acid 
decarboxylase (GAD), islet antigen 2 (IA-2), or zinc transport-
er 8 [3]. It is now clear that environmental factors also play a 
role in disease development [4].
Factors like maternal age at delivery, infections in early 
life, deficiency of specific nutrients during pregnancy, and/
or early childhood have been associated with risk of T1DM 
[4]. Other suggested environmental risk factors for T1DM are 
alterations in gut microbiota and lack of general exposure to 
microbial factors [5].
The prevalence of T1DM in children and young people 
in Portugal is 0.16% between 0 and 19 years of age. In 2014, 
there were 17.5 new cases per 100,000 young people between 
the ages of 0 and 14 [6]. Portuguese people should be consum-
ing a mediterranean diet, which is a traditional dietary pattern 
of the inhabitants of the Mediterranean countries, and consid-
ered to be one of the healthiest diets, rich in many nutrients, 
namely antioxidants [7, 8]. Despite of that, there are increas-
ingly reports demonstrating a low adherence to this diet, and 
mainly between the youngest [9].
The main cause of death in T1DM is cardiovascular dis-
ease, and early endothelial dysfunction is its pathophysiology-
cal precursor, since very early [10]. Hyperglycemia is associ-
ated with increased production of free radicals and increased 
oxidative stress [11]. This is due to the increased production of 
reactive oxygen species (ROS) and decreased antioxidant state 
[12]. It was demonstrated that some non-nutrient compounds, 
such as the abundant plant phenolic substances, may contrib-
ute significantly to preventing oxidant damage [13].
Polyphenols show antioxidant activity in vitro and in vivo 
and therefore might protect from oxidative stress-related dis-
eases such as cardiovascular disease [14, 15].
Although other authors analyzed the antioxidant status in 
diabetic children, different results have been obtained, and to 
our knowledge, this is the first study to analyze a pediatric por-
tuguese diabetic population.
This work will focus on the antioxidant status profile in 
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pre-pubertal children, aiming to a possible impact of antioxi-
dant on T1DM evolution and onset of complications. The au-
thors analyzed the antioxidant status in children with estab-
lished diabetes (> 6 months after diagnosis) and compared 
with healthy controls of the same age. In order to analyze the 
antioxidant status, different assays were used, namely ferric 
reducing antioxidant power (FRAP) and Trolox equivalent 
antioxidant capacity (TEAC), both of which use organic radi-
cal producers. These methods determine the delay of radical 
generation and the ability to scavenge the radicals [16]. Total 
phenolic content (TPC) evaluates the phenolic compounds, 
that are metabolites with significant antioxidant potential [17].
Materials and Methods
Participants
Type 1 diabetic patients attending the Pediatric Endocrinol-
ogy Clinic in Hospital de S. Joao, Porto, were selected for the 
study. The study group consisted of 23 diabetic children, with 
diagnosis for more than 6 months (12 males and 11 females) 
with a median age of 7.15 years. Exclusion criteria were BMI 
> 85th centile, the presence of puberty, complications such 
as retinopathy, nephropathy or neuropathy, other diseases 
or medications. Healthy aged matched individuals (N = 12) 
served as controls. All the diabetic children were treated with 
glargin and rapid analogues (lispro, aspart or glulisin) accord-
ing to a multiple daily injections system.
The project was approved by the Institutional Ethics Com-
mitee and all the patients parents/tutors signed an informed 
consent prior to commencement of the study.
Reagents and materials
Sample preparation
The blood was collected in tubes with EDTA. Samples were 
centrifuged at 2,000 g, 15 min at room temperature. Plasma 
was separated and stored at 20 °C until analysis.
Chemicals
Gallic acid, ascorbic acid, and 6-hydroxy-2,5,7,8-tetramethyl-
chroman-2-carboxylic acid (Trolox, a water-soluble analogue 
of vitamin E) standards were from Sigma-Aldrich or Fluka. Fo-
lin-Ciocalteu reagent, sodium fluorescein, 2,2′-Azobis (2-ami-
dinopropane) dihydrochloride (AAPH) and FeCl3.6H2O were 
from Sigma-Aldrich and 2,4,6-tripyridyl-s-triazine (TPTZ) 
was from Fluka. All remaining reagents of analytical grade 
were obtained from Merck. Standard antioxidant solutions 
were daily prepared and stored in the dark at 4 °C when not 
in use. Solutions were prepared with ultra-pure water (Milli-
pore, Simplicity 185). All the spectrophotometric assays were 
performed in a Synergy HT W/TRF Multi Mode Microplate 
Reader with Gen5 2.0 software (BioTek Instruments, Winoos-
ki, VT, USA).
TPC
TPC values of plasma samples were determined by a col-
orimetric assay based on procedures described by Singleton 
and Rossi [18]. TPC was expressed as gallic acid equivalents 
(GAE; mg gallic acid/100 g of sample) through the calibra-
tion curves of gallic acid. Final results were in µg of GAE 
mL-1. Calibration curve ranged from 10 to 200 µg of GAE 
mL-1.
FRAP
FRAP values of plasma samples were determined by a col-
orimetric assay based on the method described by Benzie and 
Strain [19]. FRAP was expressed as ascorbic acid equivalents 
(AAEs; mg ascorbic acid/100 g of sample) through the calibra-
tion curve of ascorbic acid. Final results were in µg of AAE 
mL-1. Calibration curve ranged from 5 to 100 µg of AAE mL-
1.
TEAC
TEAC assay assesses the total radical scavenging capacity 
based on the ability of a compound to scavenge the stable 
ABTS•+ radical in 6 min. TEAC values of plasma samples 
were determined by a colorimetric assay based on the method 
described by Re et al [20]. The total antioxidant capacity was 
expressed as percentage of inhibition (PI), according to the 
equation: where AbsABTS•+ corresponds to the initial absorb-
ance of diluted ABTS•+ and Abssample corresponds to the ab-
sorbance of the sample after 6 min of reaction. TEAC values 
were expressed as Trolox equivalents (TEs; mg Trolox/100g of 
sample) using the standard curve of Trolox. Final results were 
in µg of TE mL-1. Calibration curve ranged from 5 to 100 µg 
of TE mL-1.
Calibration standards were daily prepared, and all samples 
were determined in triplicate. For all the analysis, we have r 
≥ 0.99.
HbA1c was determined with DCA 2000+ Analyzer (Bay-
er Inc., Tarrytown, NY, USA) immunoassay system (normal 
range: 3-6%).
Statistical analysis
Age comparision between diabetic children and controls 
groups was done with independente sample t-test and gender 
comparision between diabetic children and controls groups 
was done with Chi-square test.
Median values of TPC, FRAP and TEAC concentrations 
were reported because of the skewed distribution of data.
TPC, FRAP and TEAC values comparisions between 
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diabetic children and controls groups were done with Mann-
Whitney tests.
A linear regression was performed with logarithm of the 
logarithm of FRAP values as dependent variable and childrens 
age and group (diabetic children and controls) as independent 
variables.
A significance level of 5% was used in all the analyses.
Results
Significant differences in age and gender among diabetic chil-
dren (T1DM) and controls were not found (Table 1).
The mean duration of disease was 3.29 years in diabetic 
children. The mean HbA1c was 8.17% in diabetic children.
As obesity was considered an exclusion factor, due to pos-
sible interference with metabolic oxidative systems quantifica-
tion, both groups had a homogeneous BMI.
HbA1c in the diabetic group was higher than recomended 
by endocrine societies in general.
TPC, FRAP and TEAC values comparision between dia-
betic children and controls were presented in Table 2.
FRAP values were significantly lower in diabetic children 
compared with healthy controls (P < 0.001). There was not any 
significant difference in the TPC and the TEAC determinations 
between the groups.
Linear regression showed that the group of diabetic chil-
dren had less log FRAP concentration than the controls (β = 
-0.349, P < 0.001) even adjusted for age (β = -0.007, P = 0.616).
Discussion
Oxidative stress is determined by a balance between ROS gen-
eration and antioxidant defense mechanisms that eliminate the 
superoxide radicals and similar compounds [21]. The antioxi-
dant defense system consists of a series of specific enzymes, 
binding proteins and various low molecular weight antioxi-
dants such as ascorbic acid, cysteine, glutathione and urate 
[21]. Some elements of this system are measured in the blood 
as markers [21]. Diabetes is considered a state of increased 
oxidative stress, but the data published to date are contradic-
tory [22, 23].
Hyperglycemia generates free radicals through several 
biochemical pathways (nonenzymatic glycation, the polyol 
pathway and glucose oxidation) [24]. Free radicals can result 
in consumption of antioxidant defenses and enhanced suscep-
tibility to lipid peroxidation [24].
In this study, markers of antioxidant defense in pediatric 
patients with T1DM were evaluated.
The study included a homogeneous group of patients with 
T1DM, and compared results with healthy controls. The re-
sults obtained in this study showed that healthy children had 
significantly higher antioxidant defense activity reflected by 
FRAP. This occurred despite of the fact that diabetic children 
are stimulated to follow a particularly healthy diet, with a high-
er consumption of fruit and vegetables.
Varvarokska et al demonstrated a lower level of antioxi-
dant capacity among diabetic children, but with the same ten-
dency exhibited by their healthy siblings [25]. In our study, 
there was a clear tendency for a lower antioxidant level in dia-
betic children, in relation to the control group.
Other authors showed that in young diabetic patients, sys-
temic oxidative stress is present upon early onset of T1DM 
[26]. The fact of the diabetic children having a lower antioxi-
dant status and considering their young age (all the children 
were pre-pubertal) leads to the need of a very careful follow-
up, not only of cardiovascular risk, but also other pathological 
situations related to a higher oxidant level.
Conclusions
Young Portuguese diabetic children have a lower antioxidant 
status than healthy children. Therefore, a very careful follow-
up is necessary and it is of particular importance promoting 
healthy habits that enhance the antioxidative defenses of the 
diabetic children since the very early years.
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